180 related articles for article (PubMed ID: 37652020)
1. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses.
Yuan S; Xu F; Li X; Chen J; Zheng J; Mantzoros CS; Larsson SC
Cell Rep Med; 2023 Sep; 4(9):101174. PubMed ID: 37652020
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
3. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
5. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
6. Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.
Chen L; Peters JE; Prins B; Persyn E; Traylor M; Surendran P; Karthikeyan S; Yonova-Doing E; Di Angelantonio E; Roberts DJ; Watkins NA; Ouwehand WH; Danesh J; Lewis CM; Bronson PG; Markus HS; Burgess S; Butterworth AS; Howson JMM
Nat Commun; 2022 Oct; 13(1):6143. PubMed ID: 36253349
[TBL] [Abstract][Full Text] [Related]
7. Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development.
Li H; Zhang Z; Qiu Y; Weng H; Yuan S; Zhang Y; Zhang Y; Xi L; Xu F; Ji X; Hao R; Yang P; Chen G; Zuo X; Zhai Z; Wang C
J Hum Genet; 2023 Dec; 68(12):805-812. PubMed ID: 37537391
[TBL] [Abstract][Full Text] [Related]
8. Unveiling potential therapeutic targets for diabetes-induced frozen shoulder through Mendelian randomization analysis of the human plasma proteome.
Chen K; Tian T; Gao P; Fang X; Jiang W; Li Z; Tang K; Ouyang P; Li L
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719509
[TBL] [Abstract][Full Text] [Related]
9. Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation.
Yuan S; Gill D; Giovannucci EL; Larsson SC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e529-e537. PubMed ID: 33418132
[TBL] [Abstract][Full Text] [Related]
10. Assessing causal associations of obesity and diabetes with kidney stones using Mendelian randomization analysis.
Yuan S; Larsson SC
Mol Genet Metab; 2021; 134(1-2):212-215. PubMed ID: 34454843
[TBL] [Abstract][Full Text] [Related]
11. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
12. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
Chen L; Zhao Y; Li M; Lv G
Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
[TBL] [Abstract][Full Text] [Related]
13. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
14. Association between plasma proteome and pulmonary heart disease: A two-stage Mendelian randomization analysis.
Li S; Ding H; Li Q; Zeng X; Zhang Y; Lai C; Xie X; Tang Y; Lan J
Clin Respir J; 2024 Jun; 18(6):e13775. PubMed ID: 38830831
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort.
Cai YW; Zhang HF; Gao JW; Cai ZX; Cai JW; Gao QY; Chen ZT; Liao GH; Zeng CR; Chen N; Liu PM; Wang JF; Chen YX
Diabetes Metab; 2023 Sep; 49(5):101472. PubMed ID: 37678759
[TBL] [Abstract][Full Text] [Related]
16. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.
Dale CE; Fatemifar G; Palmer TM; White J; Prieto-Merino D; Zabaneh D; Engmann JEL; Shah T; Wong A; Warren HR; McLachlan S; Trompet S; Moldovan M; Morris RW; Sofat R; Kumari M; Hyppönen E; Jefferis BJ; Gaunt TR; Ben-Shlomo Y; Zhou A; Gentry-Maharaj A; Ryan A; ; Mutsert R; Noordam R; Caulfield MJ; Jukema JW; Worrall BB; Munroe PB; Menon U; Power C; Kuh D; Lawlor DA; Humphries SE; Mook-Kanamori DO; Sattar N; Kivimaki M; Price JF; Davey Smith G; Dudbridge F; Hingorani AD; Holmes MV; Casas JP
Circulation; 2017 Jun; 135(24):2373-2388. PubMed ID: 28500271
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.
Cao M; Cui B
Cardiovasc Diabetol; 2024 Apr; 23(1):126. PubMed ID: 38614964
[TBL] [Abstract][Full Text] [Related]
18. Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysis.
Zou X; Ye S; Tan Y
Front Endocrinol (Lausanne); 2023; 14():1339374. PubMed ID: 38274229
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
Su Z; Wan Q
Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
